TCTMD

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

The Sentinel cerebral protection system (Boston Scientific) was infrequently used during TAVI procedures performed in Germany over a recent 3-year span, and it was not associated with less clinical ...
TCTMD

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

Debris from the proximal filter of the Sentinel system, including valve tissue, arterial wall with acute thrombus, calcification, and myocardium (Photo Credit: Aloke Finn) In a small, prospective ...
MedPage Today

Brain-Protected TAVR Results in Fewer Real-World Disabling Strokes

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW YORK CITY -- ...
EurekAlert!

Embolic protection device shows no effect on stroke risk with TAVR

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Healio

Routine cerebral embolic protection shows no benefit for patients undergoing TAVR

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...
Medscape

FDA Advisory Panel Cautiously Optimistic on Sentinel Embolic-Protection Device for TAVR

SILVER SPRING, MD — Unanimously disappointed with the end point used to determine clinical benefit, advisors to the US Food and Drug Administration (FDA) agreed the Sentinel Cerebral Protection System ...
Business Wire

Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Sentinel™ Cerebral Protection ...
Business Wire

FDA Advisory Committee Strongly Supports Granting de novo Application for the First Cerebral Protection System for Transcatheter Aortic Valve Replacement (TAVR)

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that in an open public hearing of the FDA’s Circulatory System Devices Panel last week, virtually all panel members recommended the ...
Healio

Cerebral embolic protection may help prevent stroke after TAVR, but data uncertain

Please provide your email address to receive an email when new articles are posted on . In patients having TAVR, cerebral embolic protection reduced risk for periprocedural stroke in patients from the ...
MedPage Today

Sobering Efficacy Data for TriGuard 3 Deflector in TAVR

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A redesigned ...
Nasdaq

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System

MARLBOROUGH, Mass., Sept. 17, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection ...